Observational studyCancer medicine2026

Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC.

Kojiro Ohba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.